Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
about
Multitargeted therapy of cancer by silymarinAnti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overviewMolecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancerAnti-cancer efficacy of silybin derivatives -- a structure-activity relationshipThe Comparison of The Effects of Silybin and Silybin-Phosphatidylcholine on Viability and ESR Expression in Human Breast Cancer T47D Cell Line.The role of epithelial plasticity in prostate cancer dissemination and treatment resistanceSilibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulatorsSilibinin suppresses CD44 expression in prostate cancer cellsAnimal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.Complementary and alternative medicines in prostate cancer: from bench to bedside?New combination therapies with cell-cycle agentsCombinatorial strategies for cancer eradication by silibinin and cytotoxic agents: efficacy and mechanisms.Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.Combinatorial strategies employing nutraceuticals for cancer development.Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells.Silibinin prevents lung tumorigenesis in wild-type but not in iNOS-/- mice: potential of real-time micro-CT in lung cancer chemoprevention studies.
P2860
Q24655042-B40F5862-A0F4-4DF6-8B1F-B7E3EEF9973FQ26745650-34EC6735-989D-4F53-8F7F-5A9B6ED006C9Q26995304-C21B2302-E262-4FF2-BBCB-728C06B0606DQ28489104-D5478BCA-27A8-4E9A-B176-4ABDBE488923Q34376252-F0CB57BC-F296-467C-8990-CECE55BB2790Q34505037-45892122-C610-4527-A233-048BF706D1FBQ34627739-2F2E7604-D729-4DBA-AA34-B5365587FE22Q34659546-3B735A32-4DAF-4783-884E-973405BFE87FQ35746535-6E5DBBD5-F458-49FF-A3C4-6E66CF8F2369Q36051522-8805D809-9D28-4287-9266-F706C34392A2Q36737314-75882A67-609D-411A-9634-973B4FF9AF34Q36920794-1E09465C-FB08-491E-91EE-ACDE22C72C98Q37591742-C199433A-D699-4D5E-9C14-026EE20F0784Q37906730-A88B16B1-AD4F-4BAB-B3CE-1D6B744C4185Q38819571-C0536BA3-C3D0-4C93-9DDE-477D17D6C77EQ39709029-023D5670-B8FF-4B2D-85A7-93AC136B8425Q42139184-3A9CDBB9-4AE1-4FE7-8B7F-A68A31F446C0
P2860
Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Silibinin synergizes with mito ...... n human prostate cancer cells.
@en
type
label
Silibinin synergizes with mito ...... n human prostate cancer cells.
@en
prefLabel
Silibinin synergizes with mito ...... n human prostate cancer cells.
@en
P2093
P356
P1476
Silibinin synergizes with mito ...... n human prostate cancer cells.
@en
P2093
Gail Harrison
Leonard Michael Glodé
Lih-Jen Su
Rajesh Agarwal
Thomas W Flaig
P2860
P304
P356
10.1002/IJC.22465
P577
2007-05-01T00:00:00Z